Blinatumomab Antibody
Blinatumomab is a bispecific T-cell engager antibody that targets CD19 on B-cells and CD3 on T-cells, redirecting T-cell cytotoxicity to malignant cells. It is utilized in research models of B-cell malignancies, including acute lymphoblastic leukemia and non-Hodgkin's lymphoma, for both in vitro cytotoxicity assays and in vivo efficacy studies.
Product Specifications
Product Name Alternative
MT103, MT-103, Anatumomab, Blinatumomab, bscCD19xCD3, AMG10, AMG-10
Target
Integrin, Immunology/Inflammation related
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Signal Transduction
Concentration
4.29 mg/mL
Purity
>90% (May vary between batches)
Molecular Weight
54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Sarcomeric Actinin Alpha 2 / ACTN2 (ACTN2/3295), CF594 conjugate, 0.1mg/mL
